Abstract
The genes involved in the transformation of kidney blastema cells were searched for in avian nephroblastomas induced by the MAV2 retrovirus. The twist gene was identified as a common site of provirus integration in tumor cells. Twist was rearranged by the MAV2 provirus in three out of 76 independent nephroblastoma samples. The MAV2 integration sites were localized within 40 nucleotides of the twist 5′UTR region, right upstream from the ATG initiation codon. The integrated proviruses were deleted at their 5′ends. As a consequence, twist transcription became controlled by the retroviral 3′LTR promoter and was strongly upregulated, more than 200 times. In addition, 2–100 times elevated twist transcription was also detected in the majority of other nephroblastoma samples not containing MAV2 in the twist locus. We propose that chicken nephroblastoma originates from a single blastemic cell in which the MAV retrovirus, through its integration, has deregulated specific combinations of genes controlling proliferation and differentiation. The activation of the twist gene expression appears to contribute to tumorigenesis, as there is an in vivo positive selection of tumor cell clones containing the twist gene hyperactivated by MAV2 sequences inserted within the twist promoter.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K . (eds). (1993). Current Protocols in Molecular Biology. Green Publishing Associates, Inc.
Baskaran N, Kandpal RP, Bhargava AK, Glynn MW, Bale A and Weissman SM . (1996). Genome Res., 6, 633–638.
Boni-Schnetzler M, Boni J, Ferdinand F-J and Franklin RM . (1985). J. Virol., 55, 213–222.
Bourgeois P, Bolcato-Bellemin AL, Danse JM, Bloch-Zupan A, Yoshiba K, Stoetzel C and Perrin-Schmitt F . (1998). Hum. Mol. Genet. 7, 945–957.
Castanon I and Baylies MK . (2002). Gene, 287, 11–22.
Coffin JM, Hughes SH and Varmus HE . (1997). Retroviruses. Cold Spring Harbor Laboratory Press: Plainview, NY.
Collart KL, Aurigemma R, Smith RE, Kawai S and Robinson HL . (1990). J. Virol., 64, 3541–3544.
Dome JS and Coppes MJ . (2002). Curr. Opin. Pediatr., 14, 5–11.
el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin AL, Munnich A and Bonaventure J . (1997). Nat. Genet., 15, 42–46.
Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung BM, Davidson NE and Sukumar S . (2001). The Lancet, 357, 1335–1336.
Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI, Garcia Delgado C, Gonzalez-Ramos M, Kline AD and Jabs EW . (1997). Nat. Genet., 15, 36–41.
Ishiguro H, Beard D, Sommer JR, Heine U, de The G and Beard JW . (1962). J. Natl. Cancer Inst., 29, 1–17.
Joliot V, Khelifi C, Wyers M, Dambrine G, Lasserre F, Lemercier P and Perbal B . (1996). J. Virol., 70, 2576–2580.
Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J and Perbal B . (1992). Mol. Cell. Biol., 12, 10–21.
Knudson Jr AG, Strong LC . (1972). J. Natl. Cancer. Inst., 48, 313–324.
Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA . (1999). J. Cell. Biochem., 75, 566–577.
Li L, Cserjesi P and Olson EN . (1995). Dev. Biol., 172, 280–292.
Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH and Hannon GJ . (1999). Genes. Dev., 13, 2207–1722.
Pečenka V, Dvořák M, Karafiát V, Šloncová E, Hložánek I, Trávniček M and Říman J . (1988a). Folia Biol. (Praha), 34, 147–169.
Pečenka V, Dvořák M, Karafiát V and Trávniček M . (1988c). Folia Biol. (Praha), 34, 215–232.
Pečenka V, Dvořák M and Trávniček M . (1988c). Folia Biol. (Praha), 34, 129–146
Perbal B . (2001). Mol. Pathol., 54, 57–79.
Plachý J, Hála K . (1997). Folia Biol. (Praha), 43, 133–151.
Robinson HL, Gagnon GC . (1986). J. Virol., 57, 28–36.
Scharnhorst V, van der Eb AJ and Jochemsen AG . (2001). Gene, 273, 141–161.
Spicer DB, Rhee J, Cheung WL and Lassar AB . (1996). Science, 272, 1476–1480.
Thisse B, Stoetzel C, Gorostiza-Thisse C and Perrin-Schmitt F . (1988). EMBO J., 7, 2175–2183.
Westaway D, Papkoff J, Moscovici C and Varmus HE . (1986). EMBO J., 5, 301–309.
Acknowledgements
The authors thank Petr Bartûněk and Daniel Elleder for the critical reading of the manuscript, helpful comments and discussion. The assistance of Šárka Takáčová in manuscript preparation is also greatly acknowledged. This work was supported by grants 301/98/K042 and 204/00/0554 from the Grant Agency of the Czech Republic.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pajer, P., Pečenka, V., Karafiát, V. et al. The twist gene is a common target of retroviral integration and transcriptional deregulation in experimental nephroblastoma. Oncogene 22, 665–673 (2003). https://doi.org/10.1038/sj.onc.1206105
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206105
Keywords
This article is cited by
-
Birthweight by gestational age and childhood cancer
Cancer Causes & Control (2007)
-
Embryonal nephroma in an adult fowl
Comparative Clinical Pathology (2007)
-
Integration of Myeloblastosis Associated Virus proviral sequences occurs in the vicinity of genes encoding signaling proteins and regulators of cell proliferation
Cell Communication and Signaling (2006)
-
Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells
Oncogene (2004)